Reported about 1 year ago
Billionaire investors are purchasing large amounts of shares in Pfizer and AT&T due to their high dividend yields near 6%. Pfizer offers a 5.9% yield and has been investing in new revenue sources like Padcev, with the potential to drive sales above $7 billion. AT&T, despite cutting its dividend in 2022, now provides a 6.1% yield with improved cash flows from its telecommunications services. Both companies present opportunities for passive income and potential growth for investors.
Source: YAHOO